查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018581

CBD宠物市场：2026-2032年全球市场预测（按形态、目标动物、通路和应用划分）

CBD Pet Market by Form, Animal Type, Distribution Channel, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年 CBD 宠物市场价值 3.7024 亿美元，预计到 2026 年将成长至 4.1834 亿美元，复合年增长率为 15.51%，到 2032 年将达到 10.1609 亿美元。

主要市场统计数据
基准年 2025 3.7024亿美元
预计年份：2026年 4.1834亿美元
预测年份 2032 1,016,090,000 美元
复合年增长率 (%) 15.51%

这篇以证据为基础的介绍概述了 CBD 宠物市场的演变以及影响产品安全性、可靠性和商业化的汇聚因素。

大麻二酚 (CBD) 在伴侣动物中的应用正迅速从实验性的小众配方发展成为一个更加规范的产品类型，其中兽医学、宠物护理和受监管的健康益处声明相互交织。宠物饲主越来越将他们的犬猫视为家庭成员，并要求治疗产品具备与人类产品相同的安全性和透明度。这些不断增长的期望迫使製造商和零售商采取更严格的成分揭露、第三方检测和科学传播措施，产品宣传也从单纯的轶事转向基于证据的定位。同时，监管机构和兽医协会日益严格的审查也迫使行业相关人员在产品创新、合规性和负责任的营销之间取得平衡。

消费者期望的改变、专家的认可和监管的明确化如何将 CBD 宠物产品类别转变为具有标准化安全性和治疗可信度的类别。

过去几年，CBD宠物产品类型已从分散的手工生产模式转变为以集中创新、专业化生产和数据驱动行销为特征的模式。消费者现在要求产品剂量稳定、纯度经实验室检验且使用方法清晰，这迫使品牌投资于标准化配方和生产控制。同时，兽医专业人士的态度也从怀疑转变为有条件接受，尤其是在有严格的安全数据和透明的采购流程的情况下。这种转变提高了市场进入门槛，并凸显了可靠的临床证据对于支持有关焦虑管理、运动功能支持、疼痛缓解和皮肤健康等方面的功效声明的重要性。

该评估旨在评估美国近期关税调整如何重塑 CBD 宠物产品供应链，并促进向韧性、可追溯性和国内采购的策略转变。

美国关税政策近期的变化为依赖跨境供应链获取植物来源原料、成品或製造服务的企业带来了新的挑战。传统上从国际供应商采购大麻萃取物、载体油或包装材料的企业正面临采购成本上升的困境，需要重新评估其供应商多元化策略，以维持利润率和产品品质的稳定性。这种影响不仅限于直接的成本压力，还包括更长的前置作业时间、更高的库存持有成本，以及为了降低地缘政治风险而更加重视近岸外包和国内伙伴关係。

细分市场的具体影响因产品形式、动物种类、分销管道和治疗应用而异，指南有针对性的产品开发、定位和商业化策略。

细分市场分析揭示了不同剂型、动物种类、分销管道和使用场景的扩散模式和战略挑战。就产品剂型而言，油剂因其易于给药和用途广泛而仍占据主导地位，但对高、中、低浓度油剂的需求细分，为构建分层产品系列创造了机会，以满足不同饲主的知识水平和兽医的指导需求。胶囊剂型更受老年宠物青睐，因为精准的给药计画和便捷的给药方式至关重要。另一方面，外用製剂满足局部护肤需求，并在兽医诊所和专科机构中发挥重要的沟通桥樑作用。零食是一种偏好极佳的给药方式，鼓励宠物尝试使用，而培根、鸡肉和花生酱等口味变化是影响犬类（在某些情况下也包括猫类）重复购买的关键因素。

主要地区监管立场、消费者知识水准和分销管道结构方面的差异，使得市场准入、合规和伙伴关係策略必须个性化。

区域趋势显示，监管环境、消费者行为和流通结构存在显着差异，因此需要製定个人化的市场进入和业务拓展策略。在美洲，消费者对CBD的熟悉程度以及成熟的电子商务环境促使他们快速试用，但监管政策的差异以及各州之间的差异要求企业製定周密的法律和合规计划，以避免虚假宣传和未经授权的功效声明。在该地区运营的品牌发现，投资第三方检测、打造清晰的产品故事以及与兽医诊所建立合作关係，能够提升品牌信誉，并透过专业零售商和兽医管道促进产品推广。

以品质主导差异化、策略製造伙伴关係和通路创新为特征的竞争格局正在决定可持续的竞争优势。

竞争动态由众多参与者共同塑造，从探索天然辅助疗法的成熟动物用药品公司到专注于大麻素宠物护理的专业Start-Ups，不一而足。主要企业透过投资生产品质、临床检验和透明的供应链实践来脱颖而出，从而建立值得信赖的产品故事。拥有符合GMP标准的生产设施和检验的分析能力的契约製造製造商和联合包装合作伙伴，实际上已成为战略合作伙伴，帮助品牌在保持合规性和一致性的同时拓展业务。

整合品质保证、临床检验、供应链弹性和全通路部署的实用建议，以加速可靠成长。

产业领导企业应优先考虑采取协调一致的方法，平衡监管合规、临床检验和跨通路商业化。首先，企业需要投资严格的品质保证系统和透明的第三方检测，建立从原材料到成品的可追溯性，从而在确保安全性的同时满足监管应对力。同时，针对焦虑管理、运动功能支持、疼痛缓解以及皮肤发炎和搔痒等问题开展有针对性的临床试验和真实世界数据（REW）项目，将显着提升产品功效声明的可信度，并加强与兽医专业人士的联繫。

采用综合混合方法的研究途径，结合专家访谈、产品审核以及监管和临床文献审查，确保研究结果的可靠性和可重复性。

本调查方法结合了定性访谈、结构化专家咨询、产品配方审核以及对监管文件和临床文献的系统性二次检验，以三角验证研究结果。主要研究包括对兽医、产品开发人员、采购经理和零售品类经理进行结构化访谈，以确定实际限制因素和推广驱动因素。产品审核则审查了标籤、检测结果揭露、剂量指导和包装内容，以评估市场层级的合规性和消费者透明度。

结论强调了证据、透明度和供应链韧性对于可扩展和负责任的成长的重要性。

CBD宠物产品市场正处于转折点，严格的品管、以临床为导向的产品研发以及完善的销售管道，能够将早期用户的兴趣转化为持续的治疗地位。成功的关键在于企业能否在复杂的法规环境和供应链压力下，透过可靠的测试和有针对性的证据产生来证明产品的安全性和有效性。那些重视透明度、投资专家伙伴关係并采用稳健采购模式的企业，将更有利于赢得兽医的支持和消费者的信任，从而在这个日趋成熟的市场中脱颖而出。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：CBD宠物市场：依形式划分

  • 胶囊
  • 油
    • 高浓度
    • 低浓度
    • 中等浓度
  • 外用製剂
  • 小吃
    • 培根口味
    • 鸡肉口味
    • 花生酱口味

第九章：CBD宠物市场：依动物类型划分

  • 猫
  • 狗

第十章：CBD宠物市场：依通路划分

  • 在线的
    • 品牌官方网站
    • 电子商务平台
    • 市场
  • 宠物专卖店
  • 药局
  • 动物医院

第十一章：CBD宠物市场：依应用领域划分

  • 焦虑管理
  • 运动功能支持
  • 缓解疼痛
  • 护肤
    • 发炎
    • 痒

第十二章：CBD宠物市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：CBD宠物市场：依群体划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：CBD宠物市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国CBD宠物市场

第十六章：中国CBD宠物市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abacus Health Products
  • Austin and Kat
  • BATCH CBD
  • Bluebird Botanicals
  • Canna-Pet
  • CBDistillery
  • cbdMD, Inc.
  • Charlotte's Web Holdings, Inc.
  • CV Sciences, Inc.
  • FOCL
  • Green Roads
  • HempMeds
  • HolistaPet
  • Joy Organics
  • Kazmira LLC
  • King Kanine
  • Lazarus Naturals
  • Medterra CBD
  • Penelope's Bloom
  • Pet Releaf
  • PureKana
  • VetCS
  • Wesley Edens
Product Code: MRR-B9334AD6C1DD

The CBD Pet Market was valued at USD 370.24 million in 2025 and is projected to grow to USD 418.34 million in 2026, with a CAGR of 15.51%, reaching USD 1,016.09 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 370.24 million
Estimated Year [2026] USD 418.34 million
Forecast Year [2032] USD 1,016.09 million
CAGR (%) 15.51%

An evidence-oriented introduction that frames the evolving CBD pet landscape and the converging forces shaping product safety, trust, and commercialization

The landscape for cannabidiol (CBD) applications in companion animals has evolved rapidly from experimental niche formulations to a more structured product category that intersects veterinary medicine, consumer pet care, and regulated health claims. Pet owners increasingly treat their animals as family members and demand therapeutic products that mirror human-grade safety and transparency. This growing expectation has compelled manufacturers and retailers to adopt more rigorous ingredient disclosure, third-party testing, and scientific communication, shifting product narratives away from anecdote and toward evidence-informed positioning. Concurrently, regulators and veterinary associations have elevated scrutiny, prompting industry participants to reconcile product innovation with compliance and responsible marketing.

This introduction frames the subsequent analysis by clarifying the principal drivers of category maturation: consumer sophistication, distribution channel sophistication, formulation diversification, and regulatory oversight. It highlights how these drivers interact, creating both opportunities and constraints for companies that aim to scale. The section also sets the analytical tone for the report by emphasizing a balanced view that recognizes legitimate therapeutic promise while insisting on robust safety and efficacy validation. Readers should expect an evidence-oriented approach that prioritizes practical guidance for product development, channel strategies, and stakeholder engagement across the pet care ecosystem.

How evolving consumer expectations, professional acceptance, and regulatory clarity are collectively transforming the CBD pet category toward standardized safety and therapeutic credibility

Over the past several years the CBD pet category has shifted from a fragmented assortment of artisanal products toward a market characterized by concentrated innovation, professionalized manufacturing, and data-driven marketing. Consumers now seek products that demonstrate consistent dosing, lab-verified purity, and clear application profiles, which has pushed brands to invest in standardized formulations and manufacturing controls. At the same time, veterinary professionals have moved from skepticism toward conditional acceptance, especially when products are accompanied by rigorous safety data and transparent sourcing. This shift has generated a higher bar for entry and elevated the importance of credible clinical evidence to support claims about anxiety management, mobility support, pain relief, and skin health.

Distribution has transformed in parallel. E-commerce channels have matured to support repeat purchase behavior through subscription options and tailored education, while brick-and-mortar pet specialty retailers and veterinary clinics emphasize curated assortments that align with professional recommendations. The regulatory environment has added another layer of transformation: clearer enforcement priorities and evolving frameworks for permissible claims have forced companies to refine labeling, invest in compliance, and engage proactively with advisors and policymakers. Collectively, these changes are enabling a transition from experimental consumer trial to sustained therapeutic positioning for products that can demonstrably meet pet health needs.

Assessing how recent United States tariff adjustments are reshaping CBD pet supply chains and driving strategic shifts toward resilience, traceability, and domestic sourcing

Recent tariff policy shifts in the United States have introduced new layers of complexity for firms that rely on cross-border supply chains for botanical inputs, finished products, or manufacturing services. Companies that historically sourced raw hemp extracts, carrier oils, or packaging components from international suppliers face elevated procurement costs and must re-evaluate supplier diversification strategies to maintain margin and product consistency. The cumulative impact extends beyond direct cost pressures to include prolonged lead times, increased inventory carrying considerations, and a renewed emphasis on nearshoring or domestic partnerships to mitigate geopolitical exposure.

As a practical consequence, product roadmaps and launch timelines are under greater scrutiny. Procurement teams are increasingly tasked with dual objectives: secure raw material quality while reducing logistical vulnerability. This dynamic incentivizes vertical integration for some manufacturers and strategic contracting for others, such as long-term supply agreements with certified domestic processors or shared-risk co-manufacturing arrangements. In addition, the tariff-driven reconfiguration of supply chains is accelerating investments in quality assurance infrastructure and traceability systems, which in turn enhance product safety narratives and can serve as competitive differentiators in channels that demand proven provenance and compliance.

Segment-specific implications across form, animal type, channel, and therapeutic application that inform targeted product development, positioning, and commercialization strategies

Segmentation analysis reveals differentiated adoption patterns and tactical imperatives across form factors, animal types, distribution channels, and application use-cases. In terms of product form, oils remain central due to ease of dosing and perceived versatility, but demand segmentation between high concentration, medium concentration, and low concentration oils creates opportunities for tiered portfolios that match owner sophistication and veterinary guidance. Capsules appeal to precision dosing regimens and older pet populations where ease of administration is critical, whereas topicals meet localized skin care needs and create strong point-of-sale conversation starters in clinic and specialty settings. Treats provide a palatable delivery vehicle that can accelerate trial, with flavor variants such as bacon, chicken, and peanut butter proving to be important determinants of repeat purchase among dogs and in some cases cats.

Animal type segmentation between cats and dogs shapes formulation, palatability research, and dosage communication, as feline and canine physiology and behavior influence both efficacy patterns and product acceptance. Distribution channel differentiation underscores the necessity of omnichannel strategies: online platforms, which include brand websites, e-commerce platforms, and marketplaces, enable subscription models, targeted education, and broad reach; pet specialty stores offer curated assortments and staff-mediated recommendations; pharmacies and veterinary clinics provide professional endorsement opportunities and controlled product narratives. Application-focused segmentation-comprising anxiety management, mobility support, pain relief, and skin care with specific attention to inflammation and itching-calls for tailored clinical evidence and targeted messaging that aligns product claims with verifiable outcomes and safety profiles.

How contrasting regulatory attitudes, consumer sophistication, and channel architectures across major regions necessitate tailored market entry, compliance, and partnership strategies

Regional dynamics present distinct regulatory landscapes, consumer behaviors, and channel structures that require bespoke strategies for market entry and scale. In the Americas, consumer familiarity with CBD and a mature e-commerce ecosystem support rapid trial, but regulatory patchworks and state-level variations necessitate careful legal and compliance planning to avoid mislabeling or unauthorized claims. Brands operating in this region find that investments in third-party testing, clear product narratives, and clinic partnerships yield credibility and facilitate placement in both specialty retail and veterinary channels.

In Europe, Middle East & Africa, a more conservative regulatory posture in several jurisdictions coexists with high interest in evidence-backed animal health solutions. Successful approaches in this region prioritize rigorous documentation, collaborations with licensed veterinary professionals, and targeted education for distributors that operate within national regulatory frameworks. Asia-Pacific demonstrates heterogeneous demand driven by rising pet ownership, premiumization trends, and an appetite for trusted imports in some markets. However, companies must navigate diverse import regulations, local manufacturing expectations, and culturally specific preferences for flavors and dosing formats, which underscores the value of strategic local partnerships and adaptive go-to-market models.

Competitive landscape characterized by quality-driven differentiation, strategic manufacturing partnerships, and channel-aligned innovation that determine sustained advantage

Competitive dynamics are shaped by a spectrum of actors ranging from established animal health companies exploring adjunct natural remedies to specialized start-ups focused exclusively on cannabinoid-based pet care. Leading players differentiate through investments in manufacturing quality, clinical validation, and transparent supply chain practices that support credible product narratives. Contract manufacturers and co-packers that demonstrate GMP-aligned facilities and validated analytical capabilities become de facto strategic partners, enabling brands to scale while maintaining compliance and consistency.

Retail and distribution partners exert influence on assortment decisions and educational outreach; veterinary clinics that adopt evidence-aligned products can materially affect adoption through point-of-care recommendations. Emerging innovators are leveraging technology-enabled services such as digital dosing guidance, tele-veterinary support, and subscription fulfillment to enhance adherence and lifetime value. Collectively, these competitive behaviors indicate that sustained advantage will come from integrating product quality, clinical evidence generation, channel-aligned go-to-market models, and customer experience design rather than from single-dimension differentiation.

Actionable recommendations that align quality assurance, clinical validation, supply chain resilience, and omnichannel commercialization to accelerate credible growth

Industry leaders should prioritize a coordinated agenda that balances regulatory compliance, clinical validation, and channel-specific commercialization. First, companies must invest in rigorous quality assurance frameworks and transparent third-party testing, establishing traceability from raw botanical input through finished product to support both safety narratives and regulatory resilience. Concurrently, targeted clinical studies and real-world evidence programs in anxiety management, mobility support, pain relief, and skin-related inflammation and itching will materially enhance the credibility of product claims and strengthen relationships with veterinary professionals.

Operationally, diversify supply chains by developing domestic processing options or long-term partnerships with certified suppliers to reduce exposure to tariff volatility. In channel strategy, adopt an omnichannel approach that leverages brand websites and e-commerce platforms for education and subscription models, while engaging pet specialty retailers and veterinary clinics for endorsement and curated placement. Finally, accelerate consumer education through transparent dosing guides and case studies that respect veterinary oversight, thereby aligning owner expectations with scientific evidence and improving adherence and long-term outcomes.

Comprehensive mixed-methods research approach combining expert interviews, product audits, and regulatory and clinical literature review to ensure robust and reproducible insights

The research methodology combines primary qualitative interviews, structured expert consultations, product formulation audits, and systematic secondary review of regulatory texts and clinical literature to triangulate findings. Primary research included structured interviews with veterinarians, formulators, procurement leaders, and retail category managers to capture real-world operational constraints and adoption drivers. Product audits examined labeling, testing disclosures, dosage guidance, and packaging claims to assess market-level compliance behavior and consumer-facing transparency.

Secondary analysis focused on regulatory guidance documents, peer-reviewed clinical studies, and industry technical standards to validate safety and efficacy narratives. Data triangulation procedures reconciled insights across sources to ensure robustness, and methodological safeguards such as sample stratification by channel and animal type were used to mitigate bias. Throughout the study, emphasis was placed on reproducible processes, transparent inclusion criteria for studies and interviews, and iterative validation with independent subject matter experts to ensure that conclusions are defensible and operationally relevant.

Conclusive synthesis highlighting the imperative for evidence, transparency, and supply chain resilience as decisive factors for scalable, responsible growth

The CBD pet category stands at an inflection point where rigorous quality practices, clinically informed product development, and channel-savvy commercialization can convert early adopter interest into sustained therapeutic positioning. Success will hinge on the ability of companies to demonstrate safety and efficacy through credible testing and targeted evidence generation, while also navigating regulatory complexity and supply chain pressures. Firms that prioritize transparency, invest in professional partnerships, and adopt resilient sourcing models will be better positioned to earn veterinary endorsement and consumer trust, creating defensible differentiation in a maturing market.

Looking ahead, the market will reward those who integrate scientific rigor with customer-centric delivery models and who can translate clinical learnings into accessible, responsibly marketed products. Leaders who move decisively to close evidence gaps, strengthen manufacturing provenance, and tailor distribution approaches by region and channel will capture disproportionate advantage as the category professionalizes. This conclusion underscores a pragmatic path forward: rigorous practices, aligned partnerships, and strategic investments in evidence and supply chain resilience will determine which organizations scale responsibly and effectively.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. CBD Pet Market, by Form

  • 8.1. Capsules
  • 8.2. Oils
    • 8.2.1. High Concentration
    • 8.2.2. Low Concentration
    • 8.2.3. Medium Concentration
  • 8.3. Topicals
  • 8.4. Treats
    • 8.4.1. Bacon Flavor
    • 8.4.2. Chicken Flavor
    • 8.4.3. Peanut Butter Flavor

9. CBD Pet Market, by Animal Type

  • 9.1. Cats
  • 9.2. Dogs

10. CBD Pet Market, by Distribution Channel

  • 10.1. Online
    • 10.1.1. Brand Websites
    • 10.1.2. E-Commerce Platforms
    • 10.1.3. Marketplaces
  • 10.2. Pet Specialty Stores
  • 10.3. Pharmacies
  • 10.4. Veterinary Clinics

11. CBD Pet Market, by Application

  • 11.1. Anxiety Management
  • 11.2. Mobility Support
  • 11.3. Pain Relief
  • 11.4. Skin Care
    • 11.4.1. Inflammation
    • 11.4.2. Itching

12. CBD Pet Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. CBD Pet Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. CBD Pet Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States CBD Pet Market

16. China CBD Pet Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abacus Health Products
  • 17.6. Austin and Kat
  • 17.7. BATCH CBD
  • 17.8. Bluebird Botanicals
  • 17.9. Canna-Pet
  • 17.10. CBDistillery
  • 17.11. cbdMD, Inc.
  • 17.12. Charlotte's Web Holdings, Inc.
  • 17.13. CV Sciences, Inc.
  • 17.14. FOCL
  • 17.15. Green Roads
  • 17.16. HempMeds
  • 17.17. HolistaPet
  • 17.18. Joy Organics
  • 17.19. Kazmira LLC
  • 17.20. King Kanine
  • 17.21. Lazarus Naturals
  • 17.22. Medterra CBD
  • 17.23. Penelope's Bloom
  • 17.24. Pet Releaf
  • 17.25. PureKana
  • 17.26. VetCS
  • 17.27. Wesley Edens

LIST OF FIGURES

  • FIGURE 1. GLOBAL CBD PET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CBD PET MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CBD PET MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CBD PET MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CBD PET MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CBD PET MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CBD PET MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CBD PET MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CBD PET MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CBD PET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CBD PET MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CBD PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CBD PET MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CBD PET MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CBD PET MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CBD PET MARKET SIZE, BY OILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CBD PET MARKET SIZE, BY OILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CBD PET MARKET SIZE, BY OILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CBD PET MARKET SIZE, BY HIGH CONCENTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CBD PET MARKET SIZE, BY HIGH CONCENTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CBD PET MARKET SIZE, BY HIGH CONCENTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CBD PET MARKET SIZE, BY LOW CONCENTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CBD PET MARKET SIZE, BY LOW CONCENTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CBD PET MARKET SIZE, BY LOW CONCENTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CBD PET MARKET SIZE, BY MEDIUM CONCENTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CBD PET MARKET SIZE, BY MEDIUM CONCENTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CBD PET MARKET SIZE, BY MEDIUM CONCENTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CBD PET MARKET SIZE, BY TOPICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CBD PET MARKET SIZE, BY TOPICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CBD PET MARKET SIZE, BY TOPICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CBD PET MARKET SIZE, BY TREATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CBD PET MARKET SIZE, BY TREATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CBD PET MARKET SIZE, BY TREATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CBD PET MARKET SIZE, BY BACON FLAVOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CBD PET MARKET SIZE, BY BACON FLAVOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CBD PET MARKET SIZE, BY BACON FLAVOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CBD PET MARKET SIZE, BY CHICKEN FLAVOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CBD PET MARKET SIZE, BY CHICKEN FLAVOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CBD PET MARKET SIZE, BY CHICKEN FLAVOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CBD PET MARKET SIZE, BY PEANUT BUTTER FLAVOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CBD PET MARKET SIZE, BY PEANUT BUTTER FLAVOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CBD PET MARKET SIZE, BY PEANUT BUTTER FLAVOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CBD PET MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CBD PET MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CBD PET MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CBD PET MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CBD PET MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CBD PET MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CBD PET MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CBD PET MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CBD PET MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CBD PET MARKET SIZE, BY BRAND WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CBD PET MARKET SIZE, BY BRAND WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CBD PET MARKET SIZE, BY BRAND WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CBD PET MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CBD PET MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CBD PET MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CBD PET MARKET SIZE, BY MARKETPLACES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CBD PET MARKET SIZE, BY MARKETPLACES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CBD PET MARKET SIZE, BY MARKETPLACES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CBD PET MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CBD PET MARKET SIZE, BY PET SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CBD PET MARKET SIZE, BY PET SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CBD PET MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CBD PET MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CBD PET MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CBD PET MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CBD PET MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CBD PET MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CBD PET MARKET SIZE, BY ANXIETY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CBD PET MARKET SIZE, BY ANXIETY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CBD PET MARKET SIZE, BY ANXIETY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CBD PET MARKET SIZE, BY MOBILITY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CBD PET MARKET SIZE, BY MOBILITY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CBD PET MARKET SIZE, BY MOBILITY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CBD PET MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CBD PET MARKET SIZE, BY PAIN RELIEF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CBD PET MARKET SIZE, BY PAIN RELIEF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CBD PET MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CBD PET MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CBD PET MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CBD PET MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CBD PET MARKET SIZE, BY INFLAMMATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CBD PET MARKET SIZE, BY INFLAMMATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CBD PET MARKET SIZE, BY ITCHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CBD PET MARKET SIZE, BY ITCHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CBD PET MARKET SIZE, BY ITCHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CBD PET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS CBD PET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL CBD PET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GCC CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 170. GCC CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 171. GCC CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 172. GCC CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GCC CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 175. GCC CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. GCC CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. G7 CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 197. G7 CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 198. G7 CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. G7 CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 202. G7 CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. G7 CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. NATO CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 206. NATO CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 207. NATO CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 208. NATO CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. NATO CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 211. NATO CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. NATO CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL CBD PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES CBD PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA CBD PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA CBD PET MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA CBD PET MARKET SIZE, BY OILS, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA CBD PET MARKET SIZE, BY TREATS, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA CBD PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA CBD PET MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA CBD PET MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA CBD PET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA CBD PET MARKET SIZE, BY SKIN CARE, 2018-2032 (USD MILLION)